Acta Med. 2022, 65: 125-132

https://doi.org/10.14712/18059694.2023.2

Primary Duodenal Melanoma: Challenges in Diagnosis and Management of a Rare Entity

Konstantina Dimopouloua, Anastasia Dimopouloub, Dimitra Dimopoulouc, Eleni Panopouloud, Andriani Zacharatoud, Paul Patapise, Nikolaos Zavrasb

aDepartment of Gastroenterology, General Hospital “Hippokration”, Athens, Greece
bDepartment of Paediatric Surgery, “ATTIKON” General University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
cSecond Department of Pediatrics, P. & A. Kyriakou Children’s Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
dSecond Department of Pathology, “ATTIKON” General University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
eThird Department of Surgery, “ATTIKON” General University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece

Received August 28, 2021
Accepted December 11, 2022

References

1. Elsayed AM, Albahra M, Nzeako UC, Sobin LH. Malignant melanomas in the small intestine: a study of 103 patients. Am J Gastroenterol 1996; 91: 1001–6.
2. Poggi SH, Madison JF, Hwu WJ, Bayar S, Salem RR. Colonic melanoma, primary or regressed primary. J Clin Gastroenterol 2000; 30: 4414. <https://doi.org/10.1097/00004836-200006000-00019>
3. Lens M, Bataille V, Krivokapic Z. Melanoma of the small intestine. Lancet Oncol 2009; 10: 516–21. <https://doi.org/10.1016/S1470-2045(09)70036-1>
4. Blecker D, Abraham S, Furth EE, Kochman ML. Melanoma in the gastrointestinal tract. Am J Gastroenterol 1999; 94: 3427–33. <https://doi.org/10.1111/j.1572-0241.1999.01604.x>
5. Kirchoff DD, Deutsch GB, Foshag LJ, Lee JH, Sim MS, Faries MB. Evolving therapeutic strategies in mucosal melanoma have not improved survival over five decades. Am Surg 2016; 82: 1–5. <https://doi.org/10.1177/000313481608200102>
6. Sohal RJ, Sohal S, Wazir A, Benjamin S. Mucosal melanoma: a rare entity and review of the literature. Cureus 2020; 12: e9483.
7. Teterycz P, Czarnecka AM, Indini A, et al. Multimodal treatment of advanced mucosal melanoma in the era of modern immunotherapy. Cancers 2020; 12.
8. Cheung MC, Perez EA, Molina MA, et al. Defining the role of surgery for primary gastrointestinal tract melanoma. J Gastrointest Surg 2008; 12: 731–8. <https://doi.org/10.1007/s11605-007-0417-3>
9. Anvari K, Gharib M, Jafarian AH, Saburi A, Javadinia SA. Primary duodenal malignant melanoma: A case report. Caspian J Intern Med 2018; 9: 312–5.
10. Li H, Fan Q, Wang Z, et al. Primary malignant melanoma of the duodenum without visible melanin pigment: a mimicker of lymphoma or carcinoma. Diagn Pathol 2012; 7: 74. <https://doi.org/10.1186/1746-1596-7-74> <PubMed>
11. Ridolfi RL, Rosen PP, Thaler H. Nevus cell aggregates associated with lymph nodes: estimated frequency and clinical significance. Cancer 1977; 39: 164–71. <https://doi.org/10.1002/1097-0142(197701)39:1<164::AID-CNCR2820390127>3.0.CO;2-T>
12. Mishima Y. Melanocytic and nevocytic malignant melanomas. Cellular and subcellular differentiation. Cancer 1967; 20: 632–49. <https://doi.org/10.1002/1097-0142(1967)20:5<632::AID-CNCR2820200510>3.0.CO;2-7>
13. Krausz MM, Ariel I, Behar AJ. Primary malignant melanoma of the small intestine and the APUD cell concept. J Surg Oncol 1978; 10: 283–8. <https://doi.org/10.1002/jso.2930100402>
14. Sachs DL, Lowe L, Chang AE, Carson E, Johnson TM. Do primary small intestinal melanomas exist? Report of a case. J Am Acad Dermatol 1999; 41: 1042–4. <https://doi.org/10.1016/S0190-9622(99)70273-2>
15. Manouras A, Genetzakis M, Lagoudianakis E, et al. Malignant gastrointestinal melanomas of unknown origin: should it be considered primary? World J Gastroenterol 2007; 13: 4027–9. <https://doi.org/10.3748/wjg.v13.i29.4027> <PubMed>
16. McGovern VJ. Spontaneous regression of melanoma. Pathology 1975; 7: 91–9. <https://doi.org/10.3109/00313027509092702>
17. Berger AC, Buell JF, Venzon D, Baker AR, Libutti SK. Management of symptomatic malignant melanoma of the gastrointestinal tract. Ann Surg Oncol 1999; 6: 155–60. <https://doi.org/10.1007/s10434-999-0155-8>
18. Kilambi R, Singh AN, Dash NR, Madhusudhan KS, Das P. Primary giant aggressive amelanotic duodenal melanoma. Ann R Coll Surg Engl 2017; 99: e131-e134. <https://doi.org/10.1308/rcsann.2016.0323> <PubMed>
19. Surjan RCT, do Prado Silveira S, Dos Santos ES, de Meirelles LR. Long-term survival after surgical treatment followed by adjuvant systemic therapy for primary duodenal melanoma. Clin J Gastroenterol 2020; 13: 532–53. <https://doi.org/10.1007/s12328-020-01112-9>
20. Coban S, Ekiz, F, Başar, O. A rare cause of upper gastrointestinal bleeding in an elderly patient: primary duodenal malignant melanoma. J Gastrointest Cancer 2013; 45: 242–3. <https://doi.org/10.1007/s12029-013-9565-8>
21. Jain S, Sharma P, Karunanithi S, Bal C, Kumar R. (18)F-FDG PET/CT imaging in a seldom case of primary malignant melanoma of duodenum. Indian J Nucl Med 2015; 30: 89–90.
22. Flechon A, Lombard-Bohas C, Saurin JC, Ponchon T, Partensky C, Scoazec JY. Malignant melanoma presenting as an ampullary tumour. Histopathology 2002; 41: 562–3. <https://doi.org/10.1046/j.1365-2559.2002.01457_3.x>
23. Mihajlovic M, Vlajkovic S, Jovanovic P, Stefanovic V. Primary mucosal melanomas: a comprehensive review. Int J Clin Exp Pathol 2012; 5: 739–53.
24. Gutman M, Inbar M, Chaitchik S, et al. Malignant melanoma of the mucous membranes. Eur J Surg Oncol 1992; 18: 307–12.
25. Sutherland CM, Chmiel JS, Henson DE, Winchester DP. Patient characteristics, methods of diagnosis, and treatment of mucous membrane melanoma in the United States of America. J Am Coll Surg 1994; 179: 561–6.
26. Atmatzidis KS, Pavlidis TE, Papaziogas BT, Papaziogas TB. Primary malignant melanoma of the small intestine: report of a case. Surg Today 2002; 32: 831–3. <https://doi.org/10.1007/s005950200161>
27. Houissa F, Bouzaidi S, Mouelhi L, et al. Diffuse primary malignant melanoma of the upper gastrointestinal tract. Gastroenterol Clin Biol 2010; 34: 85–7. <https://doi.org/10.1016/j.gcb.2009.05.016>
28. Zhou Y, Fan QP, Tian R, Su MG. Gastric 99mTc-methylene diphosphonate accumulation in a patient with primary upper gastrointestinal tract melanoma. Clin Nucl Med 2020; 45: 164–7. <https://doi.org/10.1097/RLU.0000000000002855>
29. Suganuma T, Fujisaki J, Hirasawa T, et al. Primary amelanotic malignant melanoma of the small intestine diagnosed by esophagogastroduodenoscopy before surgical resection. Clin J Gastroenterol 2013; 6: 211–6. <https://doi.org/10.1007/s12328-013-0380-3> <PubMed>
30. Bender GN, Maglinte DD, McLarney JH, Rex D, Kelvin FM. Malignant melanoma: patterns of metastasis to the small bowel, reliability of imaging studies, and clinical relevance. Am J Gastroenterol 2001; 96: 2392–400. <https://doi.org/10.1016/S0002-9270(01)02604-1>
31. Bendic A, Glavina Durdov M, Stipic R, Karaman I. Melanoma in the ampulla of Vater. Hepatobiliary Pancreat Dis Int 2013; 12: 106–8. <https://doi.org/10.1016/S1499-3872(13)60016-8>
32. Korkolis DP, Apostolaki K, Gontikakis E, et al. Primary malignant melanoma of the duodenum: aggressive management and long-term survival of an unusual oncologic entity. South Med J 2008; 101: 836–9. <https://doi.org/10.1097/SMJ.0b013e31817dfd75>
33. Tatlidil R, Mandelkern M. FDG-PET in the detection of gastrointestinal metastases in melanoma. Melanoma Res 2001; 11: 297–301. <https://doi.org/10.1097/00008390-200106000-00012>
34. Ballantyne AJ. Malignant melanoma of the skin of the head and neck. An analysis of 405 cases. Am J Surg 1970; 120: 425–31. <https://doi.org/10.1016/S0002-9610(70)80001-0>
35. Lian B, Si L, Cui C, et al. Phase II randomized trial comparing high-dose IFN-alpha2b with temozolomide plus cisplatin as systemic adjuvant therapy for resected mucosal melanoma. Clin Cancer Res 2013; 19: 4488–98. <https://doi.org/10.1158/1078-0432.CCR-13-0739>
36. Hamid O, Boasberg PD, Rosenthal K, O’Day SJ. Systemic treatment of metastatic melanoma: new approaches. J Surg Oncol 2011; 104: 425–9. <https://doi.org/10.1002/jso.22034>
37. Rothermel LD, Sarnaik AA, Khushalani NI, Sondak VK. Current immunotherapy practices in melanoma. Surg Oncol Clin N Am 2019; 28: 403–18. <https://doi.org/10.1016/j.soc.2019.02.001>
38. Ascierto PA, Accorona R, Botti G, et al. Mucosal melanoma of the head and neck. Crit Rev Oncol Hematol 2017; 112: 136–52. <https://doi.org/10.1016/j.critrevonc.2017.01.019>
39. Kaunitz GJ, Cottrell TR, Lilo M, et al. Melanoma subtypes demonstrate distinct PD-L1 expression profiles. Lab Invest 2017; 97: 1063–71. <https://doi.org/10.1038/labinvest.2017.64> <PubMed>
40. D’Angelo SP, Larkin J, Sosman JA, et al. Efficacy and safety of nivolumab alone or in combination with ipilimumab in patients with mucosal melanoma: a pooled analysis. J Clin Oncol 2017; 35: 226–35. <https://doi.org/10.1200/JCO.2016.67.9258> <PubMed>
41. Postow MA, Knox SJ, Goldman DA, et al. A prospective, phase 1 trial of nivolumab, ipilimumab, and radiotherapy in patients with advanced melanoma. Clin Cancer Res 2020; 26: 3193–201. <https://doi.org/10.1158/1078-0432.CCR-19-3936> <PubMed>
42. Tacastacas JD, Bray J, Cohen YK, et al. Update on primary mucosal melanoma. J Am Acad Dermatol 2014; 71: 366–75. <https://doi.org/10.1016/j.jaad.2014.03.031>
43. Cheng L, Lopez-Beltran A, Massari F, MacLennan GT, Montironi R. Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine. Modern Pathol 2018; 31: 24–38. <https://doi.org/10.1038/modpathol.2017.104> <PubMed>
44. Kim KB, Alrwas A. Treatment of KIT-mutated metastatic mucosal melanoma. Chin Clin Oncol 2014; 3: 35.
45. Alicea GM, Rebecca VW. Emerging strategies to treat rare and intractable subtypes of melanoma. Pigment Cell Melanoma Res 2021; 34: 44–58. <https://doi.org/10.1111/pcmr.12880> <PubMed>
46. Lerner BA, Stewart LA, Horowitz DP, Carvajal RD. Mucosal Melanoma: New insights and therapeutic options for a unique and aggressive disease. Oncology 2017; 3: e23–e32.
47. Li G, Tang X, He J, Ren H. Intestinal obstruction due to primary intestinal melanoma in a patient with a history of rectal cancer resectioning: a case report. Mol Clin Oncol 2014; 2: 233–6. <https://doi.org/10.3892/mco.2013.217> <PubMed>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive